Arcturus Therapeutics Holdings Inc (ARCT)
EBITDA Margin
-345.67%
TTM · Period ending:
ARCT EBITDA Margin
Latest reported-345.67%period ending
Latest reported-345.67%period ending
ARCT TTM EBITDA Margin (-600.73% → -345.67%)
TTM ebitda margin
High-resolution chart · PNG
ARCT ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -345.6661% | |
| -148.8953% | |
| -73.52% | |
| -69.0406% | |
| -50.1904% | |
| -48.1827% | |
| -55.9293% | |
| -41.298% | |
| -45.6444% | |
| -91.3221% | |
| -15.1741% | |
| 36.1469% | |
| 32.8364% | |
| 41.8364% | |
| 7.3651% | |
| -276.6136% | |
| -397.9886% | |
| -1,257.0432% | |
| -1,631.7825% | |
| -2,213.3364% | |
| -1,866.318% | |
| -1,315.1109% | |
| -740.1719% | |
| -514.7142% | |
| -350.3199% | |
| -154.6345% | |
| -128.3371% | |
| -55.2051% | |
| -43.3439% | |
| -118.6175% | |
| -133.2381% | |
| -97.4214% | |
| -89.2574% | |
| -43.8208% | |
| -28.1491% | |
| -115.4845% | |
| -238.628% | |
| -600.729% |